EXAI STOCKHOLDERS – Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Exscientia plc Class Action
June 05, 2024 16:10 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Exscientia plc's (EXAI) Former CEO's Conduct Violated the Company's Code of Business Conduct
Altimmune, Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Altimmune, Inc. (ALT) Class Action
May 15, 2024 14:43 ET
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability and Efficacy of its Weight Loss Drug
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
May 07, 2024 08:30 ET
|
Liquidia Corporation
Liquidia Corporation (NASDAQ: LQDA) announced today it will provide an update on the company at the BofA Securities Health Care Conference 2024.
BetterLife Advances BETR-001 IND-enabling Studies
May 01, 2024 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Pharma to Host Investors Update Call on September 18, 2023
September 14, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001
September 12, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, Sept. 12, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivatives
June 27, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 27, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife Continues Progress on BETR-001 IND-Enabling Studies
June 08, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, June 08, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 20, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...
BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article
March 29, 2023 08:00 ET
|
BetterLife Pharma Inc.
VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on...